FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a method for preparing a magnet-sensitive lipid composition. The declared method involves preparing a therapeutic agent containing cisplatin, a source of phospholipids and a magnetism carrier representing pirocarbon-coated ferric nanoparticles to be exposed to UV radiation. The above phospholipid source is the pharmacopeial drug 'Phosphogliv' with the composite prepared in the micellar form.
EFFECT: providing the uniformity and thermodynamic stability of the composite prepared over a short optimum period of time with using no organic solvents.
1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING MAGNETOSENSITIVE LIPOSOMES | 2007 |
|
RU2357724C1 |
PHOSPHOLIPID NANOFORM FOR ORAL APPLICATION (SACHET) AND METHOD FOR PREPARING IT (VERSIONS) | 2010 |
|
RU2463057C2 |
NANOFORM OF PHOSPHOLIPID PREPARATION FOR ORAL APPLICATION AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2373924C1 |
METHOD FOR PREPARING CAPSULATED MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304431C2 |
METHOD OF TREATING CHRONIC GASTRODUODENITIS IN CHILDREN AGED 6 AND OLDER WITH CHEMICAL CONTAMINATION OF INTERNAL BIOLOGICAL ENVIRONMENTS | 2009 |
|
RU2421233C1 |
AGENT FOR COMPLEX THERAPY OF CHRONIC DERMATOSIS, PSORIASIS, ATOPIC DERMATITIS, ECZEMA AND XERODERMIA AND METHOD OF TREATMENT OF CHRONIC DERMATOSIS | 2001 |
|
RU2196585C2 |
METHOD OF PRODUCING MAGNETIC LIPOSOMES | 2018 |
|
RU2697802C1 |
COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
METHOD FOR PREPARING INJECTION MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304430C2 |
METHOD OF TREATING PSORIASIS VULGARIS | 2012 |
|
RU2476228C1 |
Authors
Dates
2013-12-27—Published
2012-01-10—Filed